AT1 4.55% 2.3¢ atomo diagnostics limited

Ann: Government funded procurement of Atomo HIV tests commencing, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,222 Posts.
    lightbulb Created with Sketch. 157
    How many HIV tests do you think are going to be publicly purchased through the vending machines for home tests? This isn't like buying a coke from the vending machine. You need to consider the number of potential HIV positive / symptomatic people out there, who don't go to the doctor for a check, who know this is available, who are comfortable to home test themselves.

    https://hotcopper.com.au/data/attachments/6239/6239609-723f1e8ee8485c68e4407f9e88fd40d5.jpg
    https://hotcopper.com.au/data/attachments/6239/6239613-716a5d9bd678f9586c9bf819831505a3.jpg


    Further, it isn't 70 machines in SA alone. It is up to 70 nationally. It is only 6 in SA.

    Assuming the $25,000 under the pilot program was from the 6 machines being 100% sold out, then that is $295K per year in revenue. Add to the recent quarterly, gives you around $500K a quarter in revenue from HIV tests and its partner tests.

    https://hotcopper.com.au/data/attachments/6239/6239619-6849e016192b3ebef429c111a55ce1e2.jpg


    Assuming the above is accurate, if you look at the number HIV positive people and look at 1-2 partners per person (likely best case scenario?) then 4 tests per year against 90,000 people would be circa $10Million a year in tests. There could be more or less than this figure, but that's a ballpark indicator to run off.

    AT1 needs to sign on more OEM partners using the pascal units etc for tests and the best evidence of the test usage is LDX Febridx test. Further menu items for AT1 devices white labelled or developed through other manufacturers would be the way to drive further sales.

    I would keep an eye on the LDX quarterlies to give you a better idea of uptake as well as CLIA waiver for Febridx to see real value of the pascal cassette.

    At present, LDX is selling around $300K-$700K worth of product each quarter and so far, not much of that is Febridx/Pascal. The upcoming quarter and winter season will be a good indicator.

    Further to the above with LDX, there was indicators that Febridx may be licenced to other manufacturers in the US as well. This may then further drive revenue for AT1 via pascal units sold.


 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.3¢
Change
0.001(4.55%)
Mkt cap ! $14.70M
Open High Low Value Volume
2.0¢ 2.3¢ 2.0¢ $1.21K 55.02K

Buyers (Bids)

No. Vol. Price($)
5 314348 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 152314 2
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.